U.S. Physical Therapy Inc. (USPH)
USPH trades on NYSE in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/885978/000114036126007170/0001140361-26-007170-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | USPH on NYSE |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 1992 |
| SEC CIK | 0000885978 |
| SEC industry code | Services-Health Services |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $781.0M |
| Net income | $39.6M |
| Operating income | $86.7M |
| Net margin | 5.1% |
| Operating margin | 11.1% |
| Revenue growth | +16.3% |
| Cash | $35.6M |
| Total assets | $1.2B |
| P/E (computed) | 37.5× |
| P/S (computed) | 1.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $38.2M cash; operating cash flow $22.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 14,928,461 (2026-11-05); 15,204,119 a year earlier; 14,987,042 three years earlier. | Cover page 2026-11-05 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Grant Thornton LLP, Houston, Texas, United States | PCAOB Form AP 2026-03-03 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $325K, sold $499K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $222.6M | $11.0M | $25.7M | $38.2M | $246.1M | $837.6M | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $214.1M | $9.9M | $34.4M | $24.9M | $220.0M | $812.2M | 10-Q 2026-08-07 |
| Q1 2026 2026-03-31 | $198.3M | $5.0M | $3.8M | $28.4M | $204.8M | $795.5M | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $202.7M | $4.2M | $24.9M | $35.6M | $162.5M | $781.0M | 10-K 2026-02-27 |
| Q3 2025 2025-09-30 | $197.1M | $13.1M | $19.9M | $31.1M | $160.3M | $758.7M | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $197.3M | $12.4M | $34.9M | $34.1M | $160.1M | $729.6M | 10-Q 2026-08-07 |
| Q1 2025 2025-03-31 | $183.8M | $9.9M | -$4.7M | $39.2M | $166.5M | $699.5M | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $180.4M | $9.2M | $19.4M | $41.4M | $153.5M | $671.3M | 10-K 2026-02-27 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2023-05-25 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-09 |
| Latest proxy | DEF 14A | 2026-04-16 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.1% |
| 1 month | +16.6% |
| 3 months | +20.3% |
| Year to date | +27.5% |
| 1 year | +39.8% |
| From 52-week high | -0.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| AHCO | AdaptHealth Corp. | $7.73 | +0.91% | $1.1B |
| ADUS | Addus HomeCare Corporation | $124.61 | +1.31% | $2.3B |
| OMDA | Omada Health Inc. | $14.49 | +1.12% | $898.9M |
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier